Windlas Biotech IPO Allotment Status, Allotment Date, Grey Market Premium: Windlas Biotech IPO allotment will take place on Wednesday August 11, 2021 and it will be listed on August 17, 2021 on both the exchanges NSE, BSE.
Windlas Biotech is going to finalise it’s initial public offering share allotment in the upcoming week. The subscription of Windlas Biotech took place between August 4 to August 6. Windlas Biotech IPO which worths Rs. 401.54 crore had received a good response from the investors and it got subscribed 22.33 times till August 6, 5 PM . The price band for the issue was fixed at Rs 448-460 per equity share. The subscription from QIB is also recorded 24.40 times. The non-institutional quota was subscribed 15.73 times while the retail quota was subscribed 23.99 times.
What is Windlas Biotech IPO allotment date?
The IPO Allotment date of Windlas Biotech is August 11, 2021 (Wednesday).
What is Windlas Biotech IPO listing date?
The IPO listing date of Windlas Biotech is August 17, 2021 (Wednesday).
Windlas Biotech IPO Grey Market Premium (GMP) Today
The current GMP – Grey Market Premium of Windlas Biotech IPO is Rs. 125 -130. In the unofficial market Windlas Biotech Grey Market Price is trading around 28%.
How to check Windlas Biotech IPO allotment status on BSE website?
- Step-1 : Go to official BSE website.(https://www.bseindia.com/investors/appli_check.aspx)
- Step-2 : Select equity in Issue type.
- Step-3 : Select ‘Windlas Biotech’ in Issue Name dropdown.
- Step-4 : Enter Application No, Pan No & hit the search button.
How to check Windlas Biotech IPO allotment status on Link Intime website?
- Step-1 : Go to Link Intime India website: (https://www.linkintime.co.in/IPO/public-issues.html)
- Step-2 : Select the ‘Windlas Biotech – IPO’ option in company dropdown.
- Step-3 : Enter Pan No./Application No./DP Client ID/Account-IFSC No. and hit the Submit button.
Windlas Biotech IPO Registrar Details
Company : Link Intime India Private Ltd
Location : C 101, 247 Park, L.B.S.Marg, Vikhroli (West), Mumbai – 400083
Phone : +91 2249186270
Email: [email protected]
What does Windlas Biotech do?
Windlas Biotech was incorporated in year 2001. Windlas Biotech provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. The company has huge experience in manufacturing solid and liquid pharmaceutical dosage forms. It is among the top domestic pharmaceutical formulations in the industry in India in terms of revenue.
The company is an associate partner of more than 100 pharmaceutical companies including Pfizer Ltd, Eris Lifesciences Ltd, Intas Pharmaceuticals Ltd and Systopic Laboratories Pvt Ltd, Sanofi India Ltd, Zydus Cadila Healthcare Ltd, Emcure Pharmaceuticals Ltd etc.
Is Windlas Biotech profitable?
Yes, Windlas Biotech has recorded total revenue of Rs. 430.7 crore in FY21 with profit of Rs. 15.6 crore. Company’s revenue has increased from Rs. 331.3 crore to Rs. 430.7 crore as compared to FY20. But the profit is slightly dropped from Rs. 16.21 crore to Rs. 15.6 crore. Still in total we can say that company is profitable at the moment by looking at company’s financials.